4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-008927
Chief Financial Officer sold 20,000 shares at an average $31.52 ($630,308)
- Chief Financial Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-02-10 | Option exercise | +20,000 | $4.07 | $81,400 | 21,000 | D: show line 1 in the form |
| Cohen Chad M Chief Financial Officer | 2020-02-10 | Sale | −3,279 | $31.90 | $104,600 | 17,721 | D: show line 2 in the form |
| Cohen Chad M Chief Financial Officer | 2020-02-10 | Sale | −16,721 | $31.44 | $525,708 | 1,000 | D: show line 3 in the form |
| Open-market sales · 20,000 sh · avg $31.52 · $630,308 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-02-10 | Option exercise · Stock Option (Right to Buy) | −20,000 | 60,000 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…